The tentative assumption for this research study is that cell death following radiation therapy will stimulate anti-tumor immunity which may provide a more permanent solution to treating cancer and discouraging tumor spread throughout the body.
In order to find out if this assumption is correct, white blood cells from the blood samples will be tested for tumor-specific immunity. Additional blood components and plasma will be frozen and stored for future examination.
We will not be able to share the results of your blood testing with you.
The blood samples will be drawn in the UCLA Radiation Oncology Clinic on the B-2 Level in the 200 Medical Plaza Building.
Michael Steinberg, M.D., Principal Investigator (310) 825-9775
UCLA Department of Radiation Oncology (310) 825-6577